134 related articles for article (PubMed ID: 26562170)
1. Cerenkov Luminescence Imaging for Accurate Placement of Radioactive Plaques in Episcleral Brachytherapy of Intraocular Tumors.
Axelsson J; Krohn J
Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7362-8. PubMed ID: 26562170
[TBL] [Abstract][Full Text] [Related]
2. Cherenkov Luminescence Imaging for Assessment of Radioactive Plaque Position in Brachytherapy of Uveal Melanoma: An In Vivo Feasibility Study.
Krohn J; Chen YC; Stabo-Eeg NO; Hamre B
Transl Vis Sci Technol; 2020 Jun; 9(7):42. PubMed ID: 32832247
[TBL] [Abstract][Full Text] [Related]
3. Dual-energy CT imaging of orbits during episcleral brachytherapy with Ru-106 plaques: A phantom study on its potential for plaque position verification.
Perisinakis K; Detorakis ET; Tzedakis A; Liakopoulos DA; Papadaki E; Damilakis J
Phys Med; 2020 May; 73():1-7. PubMed ID: 32278254
[TBL] [Abstract][Full Text] [Related]
4. Accurate estimation of dose distributions inside an eye irradiated with 106Ru plaques.
Brualla L; Sempau J; Zaragoza FJ; Wittig A; Sauerwein W
Strahlenther Onkol; 2013 Jan; 189(1):68-73. PubMed ID: 23161122
[TBL] [Abstract][Full Text] [Related]
5. Multispectral Cerenkov luminescence tomography for small animal optical imaging.
Spinelli AE; Kuo C; Rice BW; Calandrino R; Marzola P; Sbarbati A; Boschi F
Opt Express; 2011 Jun; 19(13):12605-18. PubMed ID: 21716501
[TBL] [Abstract][Full Text] [Related]
6. Independent dosimetric assessment of the model EP917 episcleral brachytherapy plaque.
Aryal P; Molloy JA; Rivard MJ
Med Phys; 2014 Sep; 41(9):092102. PubMed ID: 25186402
[TBL] [Abstract][Full Text] [Related]
7. Transillumination for accurate placement of radioactive plaques in brachytherapy of choroidal melanoma.
Krohn J; Seland JH; Monge OR; Rekstad BL
Am J Ophthalmol; 2001 Sep; 132(3):418-9. PubMed ID: 11530064
[TBL] [Abstract][Full Text] [Related]
8. An improved treatment planning and quality assurance process for Collaborative Ocular Melanoma Study eye plaque brachytherapy.
Weersink RA; Patterson S; Ballantyne H; Di Tomasso A; Borg J; Vitkin A; Rink A; Beiki-Ardakani A
Brachytherapy; 2019; 18(5):658-667. PubMed ID: 31235445
[TBL] [Abstract][Full Text] [Related]
9. Brachytherapy With 15- Versus 20-mm Ruthenium 106 Plaques Without Verification of Plaque Position Is Associated With Local Tumor Recurrence and Death in Posterior Uveal Melanoma.
Stålhammar G
Int J Radiat Oncol Biol Phys; 2023 Dec; 117(5):1125-1137. PubMed ID: 37433377
[TBL] [Abstract][Full Text] [Related]
10. On the actual state of industrial quality assurance procedures with regard to (106)Ru ophthalmic plaques.
Kaulich TW; Zurheide J; Haug T; Budach W; Nüsslin F; Bamberg M
Strahlenther Onkol; 2004 Jun; 180(6):358-64. PubMed ID: 15175870
[TBL] [Abstract][Full Text] [Related]
11. Individualized dosimetry in Ru-106 ophthalmic brachytherapy based on MRI-derived ocular anatomical parameters.
Liakopoulos DA; Perisinakis K; Solomou G; Kouvidakis A; Drakonaki EE; Bontzos G; Papadaki E; Detorakis ET
Brachytherapy; 2022; 21(6):904-911. PubMed ID: 35995724
[TBL] [Abstract][Full Text] [Related]
12. MRI and dual-energy CT fusion anatomic imaging in Ru-106 ophthalmic brachytherapy.
Detorakis ET; Perisinakis K; Drakonaki E; Liakopoulos D; Tzedakis A; Papadaki E; Tsilimbaris MK
Brachytherapy; 2021; 20(4):828-834. PubMed ID: 33785279
[TBL] [Abstract][Full Text] [Related]
13. Investigation of gold nanoparticle effects in brachytherapy by an electron emitter ophthalmic plaque.
Hashemi S; Aghamiri MR; Kahani M; Jaberi R
Int J Nanomedicine; 2019; 14():4157-4165. PubMed ID: 31239674
[No Abstract] [Full Text] [Related]
14. In Vivo 3-Dimensional Radiopharmaceutical-Excited Fluorescence Tomography.
Hu Z; Zhao M; Qu Y; Zhang X; Zhang M; Liu M; Guo H; Zhang Z; Wang J; Yang W; Tian J
J Nucl Med; 2017 Jan; 58(1):169-174. PubMed ID: 27660137
[TBL] [Abstract][Full Text] [Related]
15. A Modified Dummy Plaque for the Accurate Placement of Ruthenium-106 Plaques in Brachytherapy of Intraocular Tumours.
Krohn J
Ocul Oncol Pathol; 2015 Sep; 2(1):1-4. PubMed ID: 27172165
[TBL] [Abstract][Full Text] [Related]
16. Quantification of Cerenkov Luminescence Imaging (CLI) Comparable With 3-D PET Standard Measurements.
Habte F; Natarajan A; Paik DS; Gambhir SS
Mol Imaging; 2018; 17():1536012118788637. PubMed ID: 30043654
[TBL] [Abstract][Full Text] [Related]
17. (68)Ga-labeled 3PRGD2 for dual PET and Cerenkov luminescence imaging of orthotopic human glioblastoma.
Fan D; Zhang X; Zhong L; Liu X; Sun Y; Zhao H; Jia B; Liu Z; Zhu Z; Shi J; Wang F
Bioconjug Chem; 2015 Jun; 26(6):1054-60. PubMed ID: 25853280
[TBL] [Abstract][Full Text] [Related]
18. Feasibility study of novel endoscopic Cerenkov luminescence imaging system in detecting and quantifying gastrointestinal disease: first human results.
Hu H; Cao X; Kang F; Wang M; Lin Y; Liu M; Li S; Yao L; Liang J; Liang J; Nie Y; Chen X; Wang J; Wu K
Eur Radiol; 2015 Jun; 25(6):1814-22. PubMed ID: 25577521
[TBL] [Abstract][Full Text] [Related]
19. A Biological Tissue Adhesive and Dissolvent System for Intraocular Tumor Plaque Brachytherapy.
Zloto O; Vishnevskia-Dai V; Moisseiev J; Belkin M; Fabian ID
Ophthalmic Surg Lasers Imaging Retina; 2016 Feb; 47(2):163-70. PubMed ID: 26878450
[TBL] [Abstract][Full Text] [Related]
20. High resolution Cerenkov light imaging of induced positron distribution in proton therapy.
Yamamoto S; Toshito T; Fujii K; Morishita Y; Okumura S; Komori M
Med Phys; 2014 Nov; 41(11):111913. PubMed ID: 25370646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
